---
title: "AN2 Therapeutics (ANTX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ANTX.US/norm.md"
symbol: "ANTX.US"
name: "AN2 Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/ANTX.US.md"
datetime: "2026-03-11T13:54:31.142Z"
locales:
  - [en](https://longbridge.com/en/quote/ANTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ANTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ANTX.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/ANTX.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/ANTX.US/norm.md)


# AN2 Therapeutics (ANTX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.3089 | -0.2142 | -0.3543 | -0.2517 | -0.4272 |
| ROE | -57.90% | -36.36% | -54.90% | -35.50% | -54.82% |
| Revenue | - | - | - | - | - |
| Net income | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M |
| Operating income | -10.04M | -7.22M | -11.54M | -8.61M | -11.77M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 67.23M | 75.83M | 81.34M | 92.09M | 97.69M |
| Leverage | 1.11 | 1.10 | 1.11 | 1.13 | 1.11 |
| BVPS | 2.21 | 2.51 | 2.43 | 2.74 | 2.94 |
| Turnover | - | - | - | - | - |
| Cash & STI | 61.92M | 62.92M | 67.06M | 83.62M | 93.43M |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | - | - |
| Net debt | -61.92M | -62.92M | -67.06M | -83.62M | -93.43M |

## 現金流量表 (USD)

| 指標 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -6.38M | -7.60M | -10.62M | -5.27M | -12.01M |
| Investing CF | 6.11M | 5.83M | 9.19M | -6.88M | 18.72M |
| Financing CF | 48000.00 | 0.0000 | 65000.00 | 0.0000 | 23000.00 |
| Free CF | -3.09M | -5.65M | -7.24M | -1.76M | -6.93M |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |